Contin M - Search Results

1

Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECT.

Contin M, Martinelli P, Riva R, Dondi M, Fanti S, Pettinato C, Scaglione C, Albani F, Baruzzi A. Contin M, et al. J Neurol. 2003 Dec;250(12):1475-81. doi: 10.1007/s00415-003-0257-3. J Neurol. 2003. PMID: 14673582

2

Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.

Contin M, Riva R, Albani F, Avoni P, Baruzzi A. Contin M, et al. Ther Drug Monit. 2002 Jun;24(3):332-7. doi: 10.1097/00007691-200206000-00002. Ther Drug Monit. 2002. PMID: 12021622 Clinical Trial.

3

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.

Contin M, Sangiorgi S, Riva R, Parmeggiani A, Albani F, Baruzzi A. Contin M, et al. Ther Drug Monit. 2002 Dec;24(6):737-41. doi: 10.1097/00007691-200212000-00009. Ther Drug Monit. 2002. PMID: 12451290

4

Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring.

Contin M, Provini F, Martinelli P, Riva R, Albani F, Vetrugno R, Lombardi C, Montagna P, Baruzzi A. Contin M, et al. Clin Neuropharmacol. 2003 May-Jun;26(3):115-8. doi: 10.1097/00002826-200305000-00003. Clin Neuropharmacol. 2003. PMID: 12782912

5

Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone.

Baruzzi A, Contin M, Barbara G, Cremon C, De Giorgio R, Patrizi A, Albani F, Corinaldesi R. Baruzzi A, et al. Among authors: contin m. Clin Neuropharmacol. 2003 Jul-Aug;26(4):177-8. doi: 10.1097/00002826-200307000-00004. Clin Neuropharmacol. 2003. PMID: 12897635

6

Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.

Contin M, Martinelli P, Mochi M, Albani F, Riva R, Scaglione C, Dondi M, Fanti S, Pettinato C, Baruzzi A. Contin M, et al. Clin Neuropharmacol. 2004 May-Jun;27(3):111-5. doi: 10.1097/00002826-200405000-00004. Clin Neuropharmacol. 2004. PMID: 15190232 Clinical Trial.

7

Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.

Contin M, Albani F, Riva R, Baruzzi A. Contin M, et al. Ther Drug Monit. 2004 Aug;26(4):375-9. doi: 10.1097/00007691-200408000-00006. Ther Drug Monit. 2004. PMID: 15257066 Clinical Trial.

8

Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.

Contin M, Martinelli P, Mochi M, Riva R, Albani F, Baruzzi A. Contin M, et al. Mov Disord. 2005 Jun;20(6):734-9. doi: 10.1002/mds.20410. Mov Disord. 2005. PMID: 15747357 Clinical Trial.

9

Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.

Contin M, Balboni M, Callegati E, Candela C, Albani F, Riva R, Baruzzi A. Contin M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 15;828(1-2):113-7. doi: 10.1016/j.jchromb.2005.09.009. Epub 2005 Sep 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 16182617

10

Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome.

Vetrugno R, Contin M, Baruzzi A, Provini F, Plazzi G, Montagna P. Vetrugno R, et al. Among authors: contin m. Mov Disord. 2006 Feb;21(2):254-8. doi: 10.1002/mds.20677. Mov Disord. 2006. PMID: 16200540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters